2/18/25 - $med - I'll call BS... super spec. long2/18/25 :: VROCKSTAR :: NYSE:MED
I'll call BS... super spec. long
- it takes a lot for me to want to play EPS in this tape, but this is one i've looked at in the past, it's a multi-level-marketing company selling health/ weight loss food and selling GLP related stuffs under OPTAVIA
- but when y
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.19 USD
2.09 M USD
602.46 M USD
10.48 M
About MEDIFAST INC
Sector
CEO
Daniel R. Chard
Website
Headquarters
Baltimore
Founded
1980
FIGI
BBG000BWBW76
Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. It offers and ships OPTAVIA products directly to its customers. It focuses on coaching healthy habits through a health transformational system. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD.
MED | This Beaten Down Stock will Rise Again | LONGMedifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cerea
8/16/24 - $med - Is it worth a look at $18. weird8/16/24 :: VROCKSTAR :: NYSE:MED
Is it worth a look at $18. weird
- this one showed up on my radar again, i couldn't bear to pull the trigger in May at $22 and change
- still a melting ice cube but sales misses are narrowing Q by Q
- what really draws my attention is this thing is PILED with ca
Medifast stock is undervalued
Strong Fundamentals: Despite market fluctuations, Medifast has demonstrated a history of strong financial performance. This could indicate that the stock price doesn't fully reflect the company's underlying value.
Growth Potential: The weight management industry is substantial, and Medifast's busi
5/23/24 - $med - GLP still gotta eat, interesting swing; spec!5/23/24 - NYSE:MED - hit my greedy "take a look" target today. so here i am *taking a look*.
let's be 100% clear - this company is facing some totally chit trends, comping down 50% growth and who know where the bottom is. i'm taking a small (and i mean small) swing here for a few reasons, however
Cheap compounder unduly punished after dividend cutHot take: there's alpha in buying dividend cuts
Here's a contrarian belief I hold: dividend cuts are almost always good, because they extend the life and increase the terminal value of the company.
However, the market almost always punishes companies that cut dividends. There are two reasons for
MED Stock Hasn't Looked This Cheap In A Long TimeMedifast's stock has slid over 80% from its 2021 high, putting its major valuation metrics at levels comparable to 2008, 2011, and 2020.
Despite the massive decline, the company's financial position still seems to be quite sound - big cash position, healthy current ratio, massive profit margin and
$MED would show near x2 in shirt-term modeNYSE:MED is a company with a good perspectives on a long distance (1-2 years) with a stable metrics. On the short path (about 3 months) it can show more or less than 100% of price growth, which can be a good present for all who like to be prepared for the Christmas happy days.
Goal for me is an a
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where MED is featured.
Related stocks
Frequently Asked Questions
The current price of MED is 12.92 USD — it has increased by 1.65% in the past 24 hours. Watch MEDIFAST INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange MEDIFAST INC stocks are traded under the ticker MED.
MED stock has risen by 1.10% compared to the previous week, the month change is a −7.52% fall, over the last year MEDIFAST INC has showed a −59.29% decrease.
We've gathered analysts' opinions on MEDIFAST INC future price: according to them, MED price has a max estimate of 15.00 USD and a min estimate of 15.00 USD. Watch MED chart and read a more detailed MEDIFAST INC stock forecast: see what analysts think of MEDIFAST INC and suggest that you do with its stocks.
MED stock is 3.60% volatile and has beta coefficient of 0.12. Track MEDIFAST INC stock price on the chart and check out the list of the most volatile stocks — is MEDIFAST INC there?
Today MEDIFAST INC has the market capitalization of 141.32 M, it has decreased by −0.91% over the last week.
Yes, you can track MEDIFAST INC financials in yearly and quarterly reports right on TradingView.
MEDIFAST INC is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
MED earnings for the last quarter are 0.10 USD per share, whereas the estimation was −0.15 USD resulting in a 166.67% surprise. The estimated earnings for the next quarter are −0.27 USD per share. See more details about MEDIFAST INC earnings.
MEDIFAST INC revenue for the last quarter amounts to 119.00 M USD, despite the estimated figure of 118.05 M USD. In the next quarter, revenue is expected to reach 110.10 M USD.
MED net income for the last quarter is 801.00 K USD, while the quarter before that showed 1.13 M USD of net income which accounts for −29.05% change. Track more MEDIFAST INC financial stats to get the full picture.
MEDIFAST INC dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 7.36% and 54.38% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 15, 2025, the company has 504 employees. See our rating of the largest employees — is MEDIFAST INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIFAST INC EBITDA is 21.39 M USD, and current EBITDA margin is 3.37%. See more stats in MEDIFAST INC financial statements.
Like other stocks, MED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIFAST INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIFAST INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIFAST INC stock shows the sell signal. See more of MEDIFAST INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.